Article
Silencing of microRNA-122 enhances interferon-α signaling in the liver through regulating SOCS3 promoter methylation
6 Sept 2012
Abstract excerpt
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease worldwide. Although novel drugs against HCV are under development, the current standard therapy consists principally of interferon (IFN). To improve the response to IFN treatment by enhancing interferon-stimulated response element (ISRE)-mediated gene transcription, we screened 75 microRNAs highly expressed in hepatocytes for their...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
